Literature DB >> 15520455

An improved assay for platelet-activating factor using HPLC-tandem mass spectrometry.

John S Owen1, Robert L Wykle, Michael P Samuel, Michael J Thomas.   

Abstract

We describe an improved assay for platelet-activating factor (PAF; 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) using HPLC-tandem mass spectrometry (LC-MS/MS). The present method can readily detect as little as 1 pg (1.9 fmol) of PAF, a significant improvement over previously described LC-MS/MS methods, and gives a linear response up to 1,000 pg of PAF. Our method also overcomes the artifacts from isobaric lipids that have limited the usefulness of certain existing LC-MS/MS assays for PAF. In the course of these studies, we detected three novel lipid species in human neutrophils. One of the novel lipids appears to be a new molecular species of PAF, and the other two have chromatographic and mass spectrometric properties consistent with stearoyl-formyl-glycerophosphocholine and oleoyl-formyl-glycerophosphocholine. These observations identify previously unknown potential interferences in the measurement of PAF by LC-MS/MS. Moreover, our data suggest that the previously described palmitoyl-formyl-glycerophosphocholine is not unique but rather is a member of a new and poorly understood family of formylated lipids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15520455     DOI: 10.1194/jlr.D400029-JLR200

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Determination of platelet-activating factor by reverse phase high-performance liquid chromatography and its application in viral hepatitis.

Authors:  Hong-Cui Cao; Xiao-Ming Chen; Wei Xu
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

2.  LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.

Authors:  Naoki Shoji; Kiyotaka Nakagawa; Akira Asai; Ikuko Fujita; Aya Hashiura; Yasushi Nakajima; Shinichi Oikawa; Teruo Miyazawa
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

3.  Chronic alcohol exposure increases circulating bioactive oxidized phospholipids.

Authors:  Lili Yang; Calivarathan Latchoumycandane; Megan R McMullen; Brian T Pratt; Renliang Zhang; Bettina G Papouchado; Laura E Nagy; Ariel E Feldstein; Thomas M McIntyre
Journal:  J Biol Chem       Date:  2010-05-11       Impact factor: 5.157

4.  Platelet-Activating Factor Quantification Using Reversed Phase Liquid Chromatography and Selected Reaction Monitoring in Negative Ion Mode.

Authors:  Daniel P Pike; Celine L Hartman; Gregory J Weissler; Elisa N D Palladino; Carolyn J Albert; David A Ford
Journal:  Lipids       Date:  2016-10-18       Impact factor: 1.880

5.  Dual phase regulation of experimental allergic encephalomyelitis by platelet-activating factor.

Authors:  Yasuyuki Kihara; Satoshi Ishii; Yoshihiro Kita; Akiko Toda; Atsuyoshi Shimada; Takao Shimizu
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

6.  Lipoxin A4 and platelet activating factor are involved in E. coli or LPS-induced lung inflammation in CFTR-deficient mice.

Authors:  Haiya Wu; Jun Yang; Emily M Su; Ling Li; Caiqi Zhao; Xi Yang; Zhaowei Gao; Mengyao Pan; Peiyu Sun; Wei Sun; Yiyi Jiang; Xiao Su
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

7.  Platelet activating factor stimulates arachidonic acid release in differentiated keratinocytes via arachidonyl non-selective phospholipase A2.

Authors:  Katarina Mariann Jørgensen; Hanne Solvang Felberg; Rolf K Berge; Astrid Laegreid; Berit Johansen
Journal:  Arch Dermatol Res       Date:  2009-12-30       Impact factor: 3.017

8.  ROBO4 deletion ameliorates PAF-mediated skin inflammation via regulating the mRNA translation efficiency of LPCAT1/LPCAT2 and the expression of PAF receptor.

Authors:  Xiaoqiang Xiao; Xi Zhuang; Ciyan Xu; Haoyu Chen; Weiquan Zhu; ChiPui Pang; Mingzhi Zhang
Journal:  Int J Biol Sci       Date:  2020-02-04       Impact factor: 6.580

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.